655 related articles for article (PubMed ID: 33952300)
1. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature.
Gatechompol S; Avihingsanon A; Putcharoen O; Ruxrungtham K; Kuritzkes DR
AIDS Res Ther; 2021 May; 18(1):28. PubMed ID: 33952300
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.
Mondi A; Cimini E; Colavita F; Cicalini S; Pinnetti C; Matusali G; Casetti R; Maeurer M; Vergori A; Mazzotta V; Gagliardini R; De Zottis F; Schininà V; Girardi E; Puro V; Ippolito G; Vaia F; Capobianchi MR; Castilletti C; Agrati C; Antinori A
J Med Virol; 2021 Mar; 93(3):1796-1804. PubMed ID: 32975842
[TBL] [Abstract][Full Text] [Related]
3. HIV/SARS-CoV-2 coinfection: A global perspective.
Kanwugu ON; Adadi P
J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
[TBL] [Abstract][Full Text] [Related]
4. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
Akyala AI; Iwu CJ
Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Virologic and Immunologic Outcomes for HIV Patients With Coronavirus Disease 2019.
Hu R; Yan H; Liu M; Tang L; Kong W; Zhu Z; Liu P; Bai W; Hu X; Ding J; Wang X; Xie N
J Acquir Immune Defic Syndr; 2021 Feb; 86(2):213-218. PubMed ID: 33079905
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
[TBL] [Abstract][Full Text] [Related]
7. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.
Yang Y; Iwasaki A
Curr HIV/AIDS Rep; 2022 Feb; 19(1):5-16. PubMed ID: 34843064
[TBL] [Abstract][Full Text] [Related]
8. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups.
Nomah DK; Reyes-Urueña J; Llibre JM; Ambrosioni J; Ganem FS; Miró JM; Casabona J
Curr HIV/AIDS Rep; 2021 Dec; 18(6):518-526. PubMed ID: 34890019
[TBL] [Abstract][Full Text] [Related]
9. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
Dutta D; Liu J; Xiong H
Viruses; 2023 May; 15(5):. PubMed ID: 37243203
[TBL] [Abstract][Full Text] [Related]
10. The Interrelationship between HIV Infection and COVID-19: A Review of the Literature.
Wang Y; Lai Y
Curr HIV Res; 2024; 22(1):6-15. PubMed ID: 38151836
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Outcomes and Risk Factors Among People Living with HIV.
Spinelli MA; Jones BLH; Gandhi M
Curr HIV/AIDS Rep; 2022 Oct; 19(5):425-432. PubMed ID: 35930187
[TBL] [Abstract][Full Text] [Related]
12. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
Peng X; Ouyang J; Isnard S; Lin J; Fombuena B; Zhu B; Routy JP
Front Immunol; 2020; 11():596631. PubMed ID: 33384690
[TBL] [Abstract][Full Text] [Related]
13. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups.
Nomah DK; Reyes-Urueña J; Llibre JM; Ambrosioni J; Ganem FS; Miró JM; Casabona J
Curr HIV/AIDS Rep; 2022 Feb; 19(1):17-25. PubMed ID: 35113346
[TBL] [Abstract][Full Text] [Related]
14. Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection.
van der Mescht MA; Steel HC; de Beer Z; Abdullah F; Ueckermann V; Anderson R; Rossouw TM
Front Immunol; 2023; 14():1235914. PubMed ID: 37646024
[TBL] [Abstract][Full Text] [Related]
15. HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes.
Sharov KS
Int J Infect Dis; 2021 Jan; 102():163-169. PubMed ID: 33115677
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 Pandemic on the Clinical Follow-Up of Patients Living with HIV in Chad: A Retrospective Monocentric Investigation.
Glenet M; Takoudjou Dzomo GR; Nguemadjita C; Djimera N; Lebreil AL; N'Guyen Y; Andreoletti L
Am J Trop Med Hyg; 2024 Feb; 110(2):387-390. PubMed ID: 38150732
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH).
Gutierrez MDM; Mur I; Mateo MG; Vidal F; Domingo P
Expert Opin Pharmacother; 2021 Jun; 22(9):1127-1141. PubMed ID: 33634724
[TBL] [Abstract][Full Text] [Related]
18. Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus.
Zhao J; Liao X; Wang H; Wei L; Xing M; Liu L; Zhang Z
Clin Infect Dis; 2020 Nov; 71(16):2233-2235. PubMed ID: 32270178
[TBL] [Abstract][Full Text] [Related]
19. Presentation and outcome of COVID-19 in HIV patients with high viral loads and opportunistic infections: a case series.
Hardy YO; Amenuke DA; Hutton-Mensah KA; Chadwick DR; Larsen-Reindorf R
Ghana Med J; 2020 Dec; 54(4 Suppl):121-124. PubMed ID: 33976453
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years' Evidence Summary.
Wang Y; Xie Y; Hu S; Ai W; Tao Y; Tang H; Jing F; Tang W
Front Immunol; 2022; 13():864838. PubMed ID: 35619709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
